_edited.png)
THERMAEYE IPL
THE SOLUTION FOR INFLAMMATION AND PHOTOREJUVENATION
THERMAEYE IPL
Thermaeye treats skin and eyelid inflammation. Our approach focuses on managing underlying conditions that often manifest as symptoms such as dry eye and various skin conditions. Equipped with self-calibrating technology for ease of use and minimal maintenance.
ESTHETIC PACKAGE INCLUDED
COMPACT, NO DISPOSABLES, SELF-CALIBRATING IPL
Reduce Inflammation
Decrease pro-inflammatory mediators and boost anti-inflammatory agents.
Enhance Tear Film Quality
Improve tear osmolarity, lipid layer, and tear meniscus height by focusing on the pro inflammatory factors
Target Vascular Abnormalities
Neutralize unusual vascular formations to reduce, lessen, or improve the inflammatory processes
Improve Meibomian Glands
"IPL benefits
rosacea, improving the dysfunction of the meibomian
glands, clearing telangiectasia, and reducing erythema."
Dr. Carlos Verges, Professor of Ophthalmolgy University of Cataluna, Barcelona
Skin Rejuvenation
Stimulates collagen production and reduces fine lines, wrinkles, sun damage, and skin tone for improved skin health and appearance.
Stop Skin and Eyelid Inflammation
VERSATILE AND COST EFFECTIVE
THERMAEYE BACKED BY PEER REVIEWED CLINICAL STUDIES
*The referenced clinical study was conducted using Thermaeye IPL.
QUICKLY ADDRESSING THE ROOT CAUSES
Treatment sessions are swift, lasting about 10 minutes, making it a perfect fit for your practice's routine. Thermaeye streamlines your workflow with just 4 straightforward sessions.
Enhance clinical outcomes, practice growth, and synergize perfectly with MiBoFlo and LLLT for a comprehensive approach.
Skin and eyelid inflammation vascular
​
Inflammatory skin diseases cause blood vessels to become abnormal and release substances that lead to inflammation. When this happens near the eyes, these substances can travel to the eyelids, causing them to become inflamed and leading to eye problems. IPL (Intense Pulsed Light) is a great treatment for these types of skin issues. IPL targets the hemoglobin in the abnormal blood vessels and destroys them, which helps reduce inflammation and prevents it from affecting the eyelids.
IPL: The Transition from Dermatology to Ophthalmology
Dr. Rolando Toyos, an ophthalmologist, initially treated patients in his clinic for rosacea. The first IPL technology used in Dr. Toyos' clinic was the Dermamed Diamond Quadra. Since then, many other IPL devices have transitioned from dermatology to ophthalmology, offering the best of both worlds for patients. Additionally, the nomograms have improved significantly.
​
In 2002, Dr. Toyos noticed clinical signs of improvement in Meibomian Gland Dysfunction (MGD) and Dry Eye Disease. From 2002 to 2008, Dr. Toyos refined his nomogram and technique. Although patients were initially diagnosed with rosacea and not dry eye, they were treated with IPL for their vascular or rosacea condition. Over a series of visits, the patients' rosacea improved, and simultaneously, so did their MGD and Dry Eye Disease.
​
Photomedicine and Laser Surgery, Vol. 33, No. 1
Authors: Rolando Toyos, William McGill, and Dustin Briscoe
​
ThermaEye IPL Ophthalmology and Dermatology
ThermaEye IPL developed their own nomogram and treatment parameters with Professor Jose Salgado Borges1,2*, Professor Dr. Carlos Vergés 2, J. Lima1, March de Ribot
​
ThermaEye IPL initially adopted Dr. Toyos' nomogram as a foundational guideline. Over time, however, the team of university ophthalmologists in Spain embarked on extensive research and clinical trials to refine and enhance their approach. They meticulously developed their own nomogram and treatment parameters, tailored specifically to optimize the efficacy and safety of IPL therapy for various vascular ocular skin and inflammatory conditions. This iterative process involved rigorous testing and adjustment, ultimately resulting in a set of protocols that significantly improved patient outcomes and broadened the therapeutic potential of ThermaEye IPL technology.​​
​
​
​
Additionally, the university ophthalmologists included all Fitzpatrick skin types in their studies, ensuring that their treatment protocols were effective and safe for a diverse range of patients. Research and clinical studies are continually ongoing, contributing to the ongoing evolution and improvement of the technology and its applications. 4
1Clinsborges. Porto, Portugal
​
2Department of Ophthalmology. Hospital Universitario Dexeus. Area Oftalmológica Avanzada. Universidad Politécnica de Cataluña. Barcelona, Spain.
​
3Department of Ophthalmology. Girona Hospital, Girona University. Girona, Spain.Source: Borges JS, Vergés C, Lima J, March de Ribot F. Intense Pulsed Light (IPL) from Dermatology to Ophthalmology. J Dermatol & Skin Sci. 2021;3(3):1-3​
4 "Traditionally, people with darker skin tones (types V to VI) were not good candidates for IPL due to risks of inducing hypopigmentation and scarring. Fortunately, this problem is beginning to be solved with a new system, Thermaeye Plus."Dr. Carlos Verges, Professor of Ophthalmolgy University of Cataluna, Barcelona
​
(4) Vergés, Carlos, José Salgado-Borges, and Francesc March de Ribot. "Prospective evaluation of a new intense pulsed light, thermaeye plus, in the treatment of dry eye disease due to meibomian gland dysfunction." Journal of Optometry 14.2 (2021): 103-113.